Dr. Kopetz on the Biology of Right- Versus Left-Sided CRC

Video

In Partnership With:

Scott Kopetz, MD, PhD, FACP, associate professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the biology of right- versus left-sided colorectal cancer.

Scott Kopetz, MD, PhD, FACP, associate professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the biology of right- versus left-sided colorectal cancer (CRC).

Compelling data show a clear difference between right- and left-sided CRC, but Kopetz says it is also important to understand the biology driving this. A left-sided tumor derives from different embryologic remnants of a hindgut versus a midgut origin. Different tissues form as a result, leading to differences in the environment of the normal gastrointestinal tract around the tumor.

There also appear to be differences in the epigenetics and the methylation that occurs with aging normal epithelium, Kopetz adds. Tumor sidedness also shows differences in the exposure to different carcinogenic bile acids in these patients.

Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine